MedTrace Logo

A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar

NCT01200576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 621

Last updated 2013-03-29

No results posted yet for this study

Summary

This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.

Conditions

  • Long-term and Permanent Contraceptive Methods

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Marie Stopes International

    collaborator OTHER

  • FHI 360

    lead OTHER

Principal Investigators

  • Odile Hanitriniaina, MD · Marie Stopes International

  • Kristen Hopkins · Marie Stopes International

  • Tania Boler · Marie Stopes International

  • Markus Steiner, Ph.D. · FHI 360

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • Madagascar

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01200576 on ClinicalTrials.gov